Literature DB >> 21131532

D-4F, an apoA-1 mimetic, decreases airway hyperresponsiveness, inflammation, and oxidative stress in a murine model of asthma.

S D Nandedkar1, D Weihrauch, H Xu, Y Shi, T Feroah, W Hutchins, D A Rickaby, N Duzgunes, C A Hillery, K S Konduri, K A Pritchard.   

Abstract

Asthma is characterized by oxidative stress and inflammation of the airways. Although proinflammatory lipids are involved in asthma, therapies targeting them remain lacking. Ac-DWFKAFYDKVAEKFKEAFNH(2) (4F) is an apolipoprotein (apo)A-I mimetic that has been shown to preferentially bind oxidized lipids and improve HDL function. The objective of the present study was to determine the effects of 4F on oxidative stress, inflammation, and airway resistance in an established murine model of asthma. We show here that ovalbumin (OVA)-sensitization increased airway hyperresponsiveness, eosinophil recruitment, and collagen deposition in lungs of C57BL/6J mice by a mechanism that could be reduced by 4F. OVA sensitization induced marked increases in transforming growth factor (TGF)β-1, fibroblast specific protein (FSP)-1, anti-T15 autoantibody staining, and modest increases in 4-hydroxynonenal (4-HNE) Michael's adducts in lungs of OVA-sensitized mice. 4F decreased TGFβ-1, FSP-1, anti-T15 autoantibody, and 4-HNE adducts in the lungs of the OVA-sensitized mice. Eosinophil peroxidase (EPO) activity in bronchial alveolar lavage fluid (BALF), peripheral eosinophil counts, total IgE, and proinflammatory HDL (p-HDL) were all increased in OVA-sensitized mice. 4F decreased BALF EPO activity, eosinophil counts, total IgE, and p-HDL in these mice. These data indicate that 4F reduces pulmonary inflammation and airway resistance in an experimental murine model of asthma by decreasing oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21131532      PMCID: PMC3035686          DOI: 10.1194/jlr.M012724

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  57 in total

1.  Plasma paraoxonase activities, lipoprotein oxidation, and trace element interaction in asthmatic patients.

Authors:  Ozlem Balci Ekmekci; Orkide Donma; Hakan Ekmekci; Nurhayat Yildirim; Omer Uysal; Emine Sardogan; Hande Demirel; Tuncalp Demir
Journal:  Biol Trace Elem Res       Date:  2006       Impact factor: 3.738

2.  High-density lipoprotein modulates oxidized phospholipid signaling in human endothelial cells from proinflammatory to anti-inflammatory.

Authors:  Nima M Gharavi; Peter S Gargalovic; Irene Chang; Jesus A Araujo; Michael J Clark; Wan Lam Szeto; Andrew D Watson; Aldons J Lusis; Judith A Berliner
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-03-22       Impact factor: 8.311

3.  A computer-controlled research ventilator for small animals: design and evaluation.

Authors:  T F Schuessler; J H Bates
Journal:  IEEE Trans Biomed Eng       Date:  1995-09       Impact factor: 4.538

4.  Chronic NOS inhibition actuates endothelial-mesenchymal transformation.

Authors:  Edmond O'Riordan; Natalia Mendelev; Susann Patschan; Daniel Patschan; Jonathan Eskander; Leona Cohen-Gould; Praveen Chander; Michael S Goligorsky
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-09-08       Impact factor: 4.733

5.  D-4F, an apolipoprotein A-I mimetic peptide, inhibits the inflammatory response induced by influenza A infection of human type II pneumocytes.

Authors:  Brian J Van Lenten; Alan C Wagner; Mohamad Navab; G M Anantharamaiah; Eric Ka-Wai Hui; Debi P Nayak; Alan M Fogelman
Journal:  Circulation       Date:  2004-11-08       Impact factor: 29.690

6.  The leukotriene B4 receptor (BLT1) is required for effector CD8+ T cell-mediated, mast cell-dependent airway hyperresponsiveness.

Authors:  Christian Taube; Nobuaki Miyahara; Vanessa Ott; Brad Swanson; Katsuyuki Takeda; Joan Loader; Leonard D Shultz; Andrew M Tager; Andrew D Luster; Azzeddine Dakhama; Erwin W Gelfand
Journal:  J Immunol       Date:  2006-03-01       Impact factor: 5.422

7.  Detection of 4-hydroxynonenal (HNE) as a physiological component in human plasma.

Authors:  H Strohmaier; H Hinghofer-Szalkay; R J Schaur
Journal:  J Lipid Mediat Cell Signal       Date:  1995-01

8.  Immunochemical detection of 4-hydroxynonenal protein adducts in oxidized hepatocytes.

Authors:  K Uchida; L I Szweda; H Z Chae; E R Stadtman
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

9.  Overexpression of endothelial nitric oxide synthase suppresses features of allergic asthma in mice.

Authors:  Robert Ten Broeke; Rini De Crom; Rien Van Haperen; Vivienne Verweij; Thea Leusink-Muis; Ingrid Van Ark; Fred De Clerck; Frans P Nijkamp; Gert Folkerts
Journal:  Respir Res       Date:  2006-04-05

10.  Posttranslational association of immunoglobulin heavy chain binding protein with nascent heavy chains in nonsecreting and secreting hybridomas.

Authors:  D G Bole; L M Hendershot; J F Kearney
Journal:  J Cell Biol       Date:  1986-05       Impact factor: 10.539

View more
  38 in total

Review 1.  Crosstalk between reverse cholesterol transport and innate immunity.

Authors:  Kathleen M Azzam; Michael B Fessler
Journal:  Trends Endocrinol Metab       Date:  2012-03-10       Impact factor: 12.015

Review 2.  The interaction of ApoA-I and ABCA1 triggers signal transduction pathways to mediate efflux of cellular lipids.

Authors:  Guo-Jun Zhao; Kai Yin; Yu-Chang Fu; Chao-Ke Tang
Journal:  Mol Med       Date:  2012-03-27       Impact factor: 6.354

3.  Revisiting "Good" and "Bad" Cholesterol. The Battle over Flow through Arteries Now Shifts to Flow through Airways.

Authors:  Michael B Fessler
Journal:  Am J Respir Crit Care Med       Date:  2015-05-01       Impact factor: 21.405

4.  Apolipoprotein A-I attenuates ovalbumin-induced neutrophilic airway inflammation via a granulocyte colony-stimulating factor-dependent mechanism.

Authors:  Cuilian Dai; Xianglan Yao; Karen J Keeran; Gayle J Zywicke; Xuan Qu; Zu-Xi Yu; Pradeep K Dagur; J Philip McCoy; Alan T Remaley; Stewart J Levine
Journal:  Am J Respir Cell Mol Biol       Date:  2012-03-15       Impact factor: 6.914

Review 5.  The A's Have It: Developing Apolipoprotein A-I Mimetic Peptides Into a Novel Treatment for Asthma.

Authors:  Xianglan Yao; Elizabeth M Gordon; Amisha V Barochia; Alan T Remaley; Stewart J Levine
Journal:  Chest       Date:  2016-06-18       Impact factor: 9.410

Review 6.  Regulation of Adaptive Immunity in Health and Disease by Cholesterol Metabolism.

Authors:  Michael B Fessler
Journal:  Curr Allergy Asthma Rep       Date:  2015-08       Impact factor: 4.806

7.  Emerging roles for cholesterol and lipoproteins in lung disease.

Authors:  Kymberly M Gowdy; Michael B Fessler
Journal:  Pulm Pharmacol Ther       Date:  2012-06-15       Impact factor: 3.410

Review 8.  High-density lipoprotein: a novel target for antirestenosis therapy.

Authors:  Kai Yin; Devendra K Agrawal
Journal:  Clin Transl Sci       Date:  2014-07-15       Impact factor: 4.689

Review 9.  Surfactant Lipids at the Host-Environment Interface. Metabolic Sensors, Suppressors, and Effectors of Inflammatory Lung Disease.

Authors:  Michael B Fessler; Ross S Summer
Journal:  Am J Respir Cell Mol Biol       Date:  2016-05       Impact factor: 6.914

Review 10.  High-density lipoprotein mimetics: promises and challenges.

Authors:  Dmitri Sviridov; Alan T Remaley
Journal:  Biochem J       Date:  2015-12-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.